-
1
-
-
0029937949
-
Effect of carvedilol on morbidity and mortality in chronic heart failure
-
The US Carvedilol Heart Failure Study Group J.N.
-
M. Packer, M.R. Bristow, J.N. Cohn The US Carvedilol Heart Failure Study Group Effect of carvedilol on morbidity and mortality in chronic heart failure N Engl J Med 334 1996 1349 1355
-
(1996)
N Engl J Med
, vol.334
, pp. 1349-1355
-
-
Packer, M.1
Bristow, M.R.2
Cohn3
-
2
-
-
0033514046
-
The cardiac insufficiency bisoprolol study-II (CIBIS-II): A randomized trial
-
CIBIS-II Investigators and Committees
-
CIBIS-II Investigators and Committees The cardiac insufficiency bisoprolol study-II (CIBIS-II): a randomized trial Lancet 353 1999 9 13
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
-
3
-
-
0033549290
-
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure
-
MERIT-HF Study Group
-
MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure Lancet 343 1999 2001 2007
-
(1999)
Lancet
, vol.343
, pp. 2001-2007
-
-
-
4
-
-
0035978763
-
For the carvedilol prospective randomized cumulative survival study group effect of carvedilol on survival in severe chronic heart failure
-
M. Packer, A.J. Coats, and M.B. Fowler For the carvedilol prospective randomized cumulative survival study group effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
-
(2001)
N Engl J Med
, vol.344
, pp. 1651-1658
-
-
Packer, M.1
Coats, A.J.2
Fowler, M.B.3
-
5
-
-
3142776467
-
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): Randomized controlled trial
-
for the COMET investigators P.A.
-
P.A. Poole-Wilson for the COMET investigators Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial Lancet 362 2003 7 13
-
(2003)
Lancet
, vol.362
, pp. 7-13
-
-
Poole-Wilson1
-
6
-
-
0033910521
-
Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction
-
S. Wei, L.T. Chow, and J.E. Sanderson Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction J Am Coll Cardiol 36 2000 276 281
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 276-281
-
-
Wei, S.1
Chow, L.T.2
Sanderson, J.E.3
-
7
-
-
0033847635
-
A comparison of carvedilol and metoprolol antioxidant activities in vitro
-
P.G. Lysko, C.L. Webb, E.H. Ohlstein, R.R. Ruffolo, and T.L. Yue A comparison of carvedilol and metoprolol antioxidant activities in vitro J Cardiovasc Pharmacol 36 2000 277 281
-
(2000)
J Cardiovasc Pharmacol
, vol.36
, pp. 277-281
-
-
Lysko, P.G.1
Webb, C.L.2
Ohlstein, E.H.3
Ruffolo, R.R.4
Yue, T.L.5
-
8
-
-
0035182486
-
Antioxidant properties of carvedilol and metoprolol in heart failure: A double-blind randomized controlled trial
-
M. Arumanayagan, S. Chan, S. Tong, and J.E. Sanderson Antioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomized controlled trial J Cardiovasc Pharmacol 37 2001 48 54
-
(2001)
J Cardiovasc Pharmacol
, vol.37
, pp. 48-54
-
-
Arumanayagan, M.1
Chan, S.2
Tong, S.3
Sanderson, J.E.4
-
9
-
-
0642316363
-
COMET: A proposed mechanism of action to explain the results and concerns about dose
-
A. Hjalmarson, and F. Waagstein COMET: a proposed mechanism of action to explain the results and concerns about dose Lancet 362 2003 1077
-
(2003)
Lancet
, vol.362
, pp. 1077
-
-
Hjalmarson, A.1
Waagstein, F.2
-
10
-
-
0033230514
-
Beta-blockade in heart failure: A comparison of carvedilol with metoprolol
-
J.E. Sanderson, S.K.W. Chan, and G. Yip Beta-blockade in heart failure: a comparison of carvedilol with metoprolol J Am Coll Cardiol 34 1999 1522 1528
-
(1999)
J Am Coll Cardiol
, vol.34
, pp. 1522-1528
-
-
Sanderson, J.E.1
Chan, S.K.W.2
Yip, G.3
-
11
-
-
0346199336
-
β-Blockers prolong survival in heart failure only by inhibiting the β1-receptor? a perspective on the results of the COMET trial
-
Packer M. Do β-Blockers prolong survival in heart failure only by inhibiting the β1-receptor? A perspective on the results of the COMET trial J Card Fail 9 2003 429 441
-
(2003)
J Card Fail
, vol.9
, pp. 429-441
-
-
Do Packer, M.1
-
12
-
-
0035654146
-
Dose-related effects of metoprolol on heart rate and pharmacokinetics in heart failure
-
B. Andersson, J. Aberg, B. Lindelow, M.S. Tang, and J. Wilkstrand Dose-related effects of metoprolol on heart rate and pharmacokinetics in heart failure J Card Fail 7 2001 311 317
-
(2001)
J Card Fail
, vol.7
, pp. 311-317
-
-
Andersson, B.1
Aberg, J.2
Lindelow, B.3
Tang, M.S.4
Wilkstrand, J.5
-
13
-
-
0035370722
-
Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: Results of a meta-analysis
-
M. Packer, G.V. Antonopoulos, J.A. Berlin, J. Chittams, M.A. Konstam, and J.E. Udelson Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis Am Heart J 141 2001 899 907
-
(2001)
Am Heart J
, vol.141
, pp. 899-907
-
-
Packer, M.1
Antonopoulos, G.V.2
Berlin, J.A.3
Chittams, J.4
Konstam, M.A.5
Udelson, J.E.6
-
14
-
-
0030834418
-
Beta blockade in congestive heart failure: Persistent adverse haemodynamic effects during chronic treatment with subsequent doses
-
M.L. Kukin, J. Kalman, and M.M. Mannimo Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses Heart 78 1997 444 449
-
(1997)
Heart
, vol.78
, pp. 444-449
-
-
Kukin, M.L.1
Kalman, J.2
Mannimo, M.M.3
-
15
-
-
0033955186
-
Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure
-
M.L. Kukin, M.M. Mannimo, and R.S Freudenberger Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure J Am Coll Cardiol 35 2000 45 50
-
(2000)
J Am Coll Cardiol
, vol.35
, pp. 45-50
-
-
Kukin, M.L.1
Mannimo, M.M.2
Freudenberger, R.S.3
-
16
-
-
0033662177
-
Congestive heart failure induces endothelial cell apoptosis: Protective role of carvedilol
-
L. Rossig, J. Haendeler, and Z. Mallat Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol J Am Coll Cardiol 36 2000 2081 2089
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 2081-2089
-
-
Rossig, L.1
Haendeler, J.2
Mallat, Z.3
-
17
-
-
0029998396
-
Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: The carvedilol-metoprolol study
-
S. Jacob, Rett, M. Wicklmayr, B. Agrawal, H.J. Augustine, and G.J. Dietze Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study J Hypertens 14 1996 489 494
-
(1996)
J Hypertens
, vol.14
, pp. 489-494
-
-
Jacob, S.1
Rett2
Wicklmayr, M.3
Agrawal, B.4
Augustine, H.J.5
Dietze, G.J.6
-
18
-
-
0041562650
-
Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure
-
J.W.H. Fung, C.M. Yu, and G. Yip Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure Am J Cardiol 92 2003 406 410
-
(2003)
Am J Cardiol
, vol.92
, pp. 406-410
-
-
Fung, J.W.H.1
Yu, C.M.2
Yip, G.3
|